Jeffrey Weber
MD, PhD
Deputy Director, Perlmutter Cancer Center
👥Biography 个人简介
Jeffrey Weber is a melanoma immunotherapy leader who has worked across interferon alpha adjuvant, high-dose IL-2, and modern checkpoint blockade and mRNA cancer vaccines. He has led pivotal trials of nivolumab in melanoma and the mRNA-4157 adjuvant melanoma study. His career bridges classic cytokine therapy and modern immunotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jeffrey Weber 的研究动态
Follow Jeffrey Weber's research updates
留下邮箱，当我们发布与 Jeffrey Weber（NYU Langone Health）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment